JNJ
Price
$155.21
Change
+$1.63 (+1.06%)
Updated
May 30 closing price
Capitalization
380.22B
45 days until earnings call
RHHVF
Price
$323.35
Change
+$2.45 (+0.76%)
Updated
May 30 closing price
Capitalization
250.69B
53 days until earnings call
Interact to see
Advertisement

JNJ vs RHHVF

Header iconJNJ vs RHHVF Comparison
Open Charts JNJ vs RHHVFBanner chart's image
Johnson & Johnson
Price$155.21
Change+$1.63 (+1.06%)
Volume$15.53M
Capitalization380.22B
Roche Holding
Price$323.35
Change+$2.45 (+0.76%)
Volume$19.32K
Capitalization250.69B
JNJ vs RHHVF Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. RHHVF commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and RHHVF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (JNJ: $155.21 vs. RHHVF: $323.35)
Brand notoriety: JNJ: Notable vs. RHHVF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 165% vs. RHHVF: 161%
Market capitalization -- JNJ: $380.22B vs. RHHVF: $250.69B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. RHHVF’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileRHHVF’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • RHHVF’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than RHHVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 6 TA indicator(s) are bullish while RHHVF’s TA Score has 6 bullish TA indicator(s).

  • JNJ’s TA Score: 6 bullish, 3 bearish.
  • RHHVF’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RHHVF is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а +2.35% price change this week, while RHHVF (@Pharmaceuticals: Major) price change was +3.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.93%. For the same industry, the average monthly price growth was +1.41%, and the average quarterly price growth was +0.61%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 16, 2025.

RHHVF is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.93% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than RHHVF($251B). JNJ has higher P/E ratio than RHHVF: JNJ (30.34) vs RHHVF (19.34). RHHVF YTD gains are higher at: 15.482 vs. JNJ (9.109). JNJ has higher annual earnings (EBITDA): 23.3B vs. RHHVF (19.1B). JNJ has more cash in the bank: 22.9B vs. RHHVF (7.51B). RHHVF has less debt than JNJ: RHHVF (25.4B) vs JNJ (29.3B). JNJ has higher revenues than RHHVF: JNJ (85.2B) vs RHHVF (60B).
JNJRHHVFJNJ / RHHVF
Capitalization380B251B151%
EBITDA23.3B19.1B122%
Gain YTD9.10915.48259%
P/E Ratio30.3419.34157%
Revenue85.2B60B142%
Total Cash22.9B7.51B305%
Total Debt29.3B25.4B115%
FUNDAMENTALS RATINGS
JNJ vs RHHVF: Fundamental Ratings
JNJ
RHHVF
OUTLOOK RATING
1..100
1550
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
13
Undervalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
33100
PRICE GROWTH RATING
1..100
5549
P/E GROWTH RATING
1..100
7514
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHVF's Valuation (13) in the null industry is in the same range as JNJ (15) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHVF (100) in the null industry. This means that JNJ’s stock grew somewhat faster than RHHVF’s over the last 12 months.

JNJ's SMR Rating (33) in the Pharmaceuticals Major industry is significantly better than the same rating for RHHVF (100) in the null industry. This means that JNJ’s stock grew significantly faster than RHHVF’s over the last 12 months.

RHHVF's Price Growth Rating (49) in the null industry is in the same range as JNJ (55) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew similarly to JNJ’s over the last 12 months.

RHHVF's P/E Growth Rating (14) in the null industry is somewhat better than the same rating for JNJ (75) in the Pharmaceuticals Major industry. This means that RHHVF’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJRHHVF
RSI
ODDS (%)
Bullish Trend 3 days ago
34%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
44%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
40%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
30%
Bullish Trend 3 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
42%
Bullish Trend 3 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
40%
Bearish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 3 days ago
40%
Bullish Trend 3 days ago
53%
Declines
ODDS (%)
Bearish Trend 11 days ago
43%
Bearish Trend 11 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
45%
Bullish Trend 3 days ago
54%
Aroon
ODDS (%)
Bearish Trend 3 days ago
33%
Bullish Trend 3 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSIEX79.360.23
+0.29%
Calvert Equity A
PGHAX60.780.17
+0.28%
Putnam Global Health Care R6
TLGYX59.52-0.02
-0.03%
Touchstone Large Company Growth Y
GCLSX23.59-0.03
-0.13%
Goldman Sachs Large Cp Val Insghts Svc
CUSRX12.04-0.19
-1.55%
Cullen Small Cap Value Retail

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+1.06%
PFE - JNJ
59%
Loosely correlated
+0.17%
NVS - JNJ
53%
Loosely correlated
+2.82%
GSK - JNJ
47%
Loosely correlated
+2.57%
SNY - JNJ
44%
Loosely correlated
-5.69%
ABBV - JNJ
44%
Loosely correlated
+0.26%
More

RHHVF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHVF has been loosely correlated with RHHBY. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHVF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHVF
1D Price
Change %
RHHVF100%
+0.76%
RHHBY - RHHVF
65%
Loosely correlated
+1.96%
JNJ - RHHVF
31%
Poorly correlated
+1.06%
NVS - RHHVF
27%
Poorly correlated
+2.82%
AZN - RHHVF
26%
Poorly correlated
+2.77%
RHHBF - RHHVF
25%
Poorly correlated
+0.25%
More